Target intelligence / Profile preview

Coiled-coil domain-containing protein 25 (CCDC25)

Target
CCDC25
Molecular classification
Other, Transmembrane receptor, DNA binding protein
01

Overview

Coiled-coil domain-containing protein 25 (CCDC25) is a highly conserved, 208-amino-acid human protein encoded on chromosome 8p21.1. It is expressed in a wide range of tissues and localizes mainly to the cell membrane and cytoplasm. Functionally, CCDC25 acts as a transmembrane receptor for DNA associated with neutrophil extracellular traps (NETs). Upon binding to NET DNA, CCDC25 activates the ILK-PARVB signaling pathway, leading to actin cytoskeleton rearrangement and enhanced cell migration. This mechanism is especially implicated in promoting tumor metastasis: NETs in the tumor microenvironment use CCDC25 to attract circulating tumor cells and encourage metastatic spread[2][3][6]. Beyond metastasis, CCDC25 is upregulated and released by tumor cells in cholangiocarcinoma and can be detected in serum, where its levels effectively discriminate malignant from benign and healthy states, showing potential as a high-sensitivity, high-specificity diagnostic biomarker[4][6]. The broad biological roles of CCDC25 are still being elucidated; however, its established role in cancer biology and emerging utility as a biomarker designate it as a promising therapeutic and diagnostic target.

Other names
CCDC25Coiled-coil domain containing 25FLJ10853
02

Mechanism of action

Triggering cell migration via binding to DNA from neutrophil extracellular traps (NETs) and activating intracellular signal transduction (ILK-PARVB pathway)

03

Biological functions

Positive regulation of cell motilityDNA bindingPromotion of cancer metastasis via detection of neutrophil extracellular traps (NETs)Signal transduction (via ILK-PARVB pathway)
04

Disease associations

Cancer (metastasis, especially in the context of interaction with NETs)Cholangiocarcinoma (as a diagnostic biomarker)Chronic cholangitis (gene association)Lynch syndrome 2 (gene association)
05

Safety considerations

Potential challenges related to off-target effects if used therapeutically due to broad tissue expression and role in basic cell motility (inferred)
06

Biomarkers

Elevated serum CCDC25 levels as a biomarker for cholangiocarcinoma (diagnosis/differentiation from benign disease and healthy controls)

Beyond the preview

Go deeper on Coiled-coil domain-containing protein 25 (CCDC25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil domain-containing protein 25 (CCDC25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call